{"entity":{"type":"insider","cik":"0001302445","url":"/insider/0001302445","json_url":"/insider/0001302445.json","name":"Brinkley David L","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":65,"n_filings":17,"first":"2007-03-02","last":"2013-05-31","span_basis":"filed_date"},"name_variants":[{"name":"Brinkley David L","source":"filing","n_filings":17,"first_seen":"2007-03-02","last_seen":"2013-05-31"}],"transactions":[{"id":4622901,"accession":"0001179110-13-009448","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-13-009448","line_url":"/filing/0001179110-13-009448#line-1","is_derivative":false,"issuer_cik":"0001080014","issuer_name":"THERAVANCE INC","issuer_ticker":"THRX","issuer_name_source":null,"issuer_url":"/issuer/0001080014","owner_cik":"0001302445","owner_name":"Brinkley David L","owner_display_name":"Brinkley David L","owner_url":"/insider/0001302445","role":"Officer (Head of Business Dev)","role_mark":"O","role_mark_label":"Officer (Head of Business Dev)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Head of Business Dev.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3808.0,"shares_display":"3,808","price_per_share":35.01,"price_display":"35.01","price_state":"stated","total_value":133318.08,"total_display":"133,318.08","total_whole":"133,318","shares_owned_after":48749.0,"shares_owned_after_display":"48,749","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-05-29","filed_date":"2013-05-31","scope":"insider"},{"id":4469775,"accession":"0001179110-13-008498","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-13-008498","line_url":"/filing/0001179110-13-008498#line-2","is_derivative":false,"issuer_cik":"0001080014","issuer_name":"THERAVANCE INC","issuer_ticker":"THRX","issuer_name_source":null,"issuer_url":"/issuer/0001080014","owner_cik":"0001302445","owner_name":"Brinkley David L","owner_display_name":"Brinkley David L","owner_url":"/insider/0001302445","role":"Officer (Head of Business Dev)","role_mark":"O","role_mark_label":"Officer (Head of Business Dev)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Head of Business Dev.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16129.0,"shares_display":"16,129","price_per_share":40.33,"price_display":"40.33","price_state":"stated","total_value":650482.57,"total_display":"650,482.57","total_whole":"650,483","shares_owned_after":55000.0,"shares_owned_after_display":"55,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-05-13","filed_date":"2013-05-15","scope":"insider"},{"id":4866209,"accession":"0001179110-13-007932","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-13-007932","line_url":"/filing/0001179110-13-007932#line-2","is_derivative":false,"issuer_cik":"0001080014","issuer_name":"THERAVANCE INC","issuer_ticker":"THRX","issuer_name_source":null,"issuer_url":"/issuer/0001080014","owner_cik":"0001302445","owner_name":"Brinkley David L","owner_display_name":"Brinkley David L","owner_url":"/insider/0001302445","role":"Officer (Head of Business Dev)","role_mark":"O","role_mark_label":"Officer (Head of Business Dev)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Head of Business Dev.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16129.0,"shares_display":"16,129","price_per_share":34.77,"price_display":"34.77","price_state":"stated","total_value":560805.33,"total_display":"560,805.33","total_whole":"560,805","shares_owned_after":55000.0,"shares_owned_after_display":"55,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-05-03","filed_date":"2013-05-07","scope":"insider"},{"id":4905984,"accession":"0001179110-13-007591","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001179110-13-007591","line_url":"/filing/0001179110-13-007591","is_derivative":false,"issuer_cik":"0001080014","issuer_name":"THERAVANCE INC","issuer_ticker":"THRX","issuer_name_source":null,"issuer_url":"/issuer/0001080014","owner_cik":"0001302445","owner_name":"Brinkley David L","owner_display_name":"Brinkley David L","owner_url":"/insider/0001302445","role":"Officer (Head of Business Dev)","role_mark":"O","role_mark_label":"Officer (Head of Business Dev)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Head of Business Dev.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17104.0,"shares_display":"17,104","price_per_share":33.763449485500466,"price_display":"33.76","price_state":"stated","total_value":577490.04,"total_display":"577,490.04","total_whole":"577,490","shares_owned_after":55100.0,"shares_owned_after_display":"55,100","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-04-30","filed_date":"2013-05-02","scope":"insider","n_lines":2},{"id":3330763,"accession":"0001179110-12-013432","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-12-013432","line_url":"/filing/0001179110-12-013432#line-1","is_derivative":false,"issuer_cik":"0001080014","issuer_name":"THERAVANCE INC","issuer_ticker":"THRX","issuer_name_source":null,"issuer_url":"/issuer/0001080014","owner_cik":"0001302445","owner_name":"Brinkley David L","owner_display_name":"Brinkley David L","owner_url":"/insider/0001302445","role":"Officer (Head of Business Dev)","role_mark":"O","role_mark_label":"Officer (Head of Business Dev)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Head of Business Dev.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3483.0,"shares_display":"3,483","price_per_share":27.5,"price_display":"27.50","price_state":"stated","total_value":95782.5,"total_display":"95,782.50","total_whole":"95,783","shares_owned_after":60241.0,"shares_owned_after_display":"60,241","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-08-24","filed_date":"2012-08-28","scope":"insider"},{"id":2189411,"accession":"0001179110-12-012533","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001179110-12-012533","line_url":"/filing/0001179110-12-012533#line-3","is_derivative":false,"issuer_cik":"0001080014","issuer_name":"THERAVANCE INC","issuer_ticker":"THRX","issuer_name_source":null,"issuer_url":"/issuer/0001080014","owner_cik":"0001302445","owner_name":"Brinkley David L","owner_display_name":"Brinkley David L","owner_url":"/insider/0001302445","role":"Officer (Head of Business Dev)","role_mark":"O","role_mark_label":"Officer (Head of Business Dev)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Head of Business Dev.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":123917.0,"shares_display":"123,917","price_per_share":27.92,"price_display":"27.92","price_state":"stated","total_value":3459762.64,"total_display":"3,459,762.64","total_whole":"3,459,763","shares_owned_after":66781.0,"shares_owned_after_display":"66,781","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-08-03","filed_date":"2012-08-07","scope":"insider"},{"id":9176864,"accession":"0001179110-11-009087","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001179110-11-009087","line_url":"/filing/0001179110-11-009087#line-7","is_derivative":false,"issuer_cik":"0001080014","issuer_name":"THERAVANCE INC","issuer_ticker":"THRX","issuer_name_source":null,"issuer_url":"/issuer/0001080014","owner_cik":"0001302445","owner_name":"Brinkley David L","owner_display_name":"Brinkley David L","owner_url":"/insider/0001302445","role":"Officer (Head of Business Dev)","role_mark":"O","role_mark_label":"Officer (Head of Business Dev)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Head of Business Dev.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":51500.0,"shares_display":"51,500","price_per_share":25.65,"price_display":"25.65","price_state":"stated","total_value":1320975.0,"total_display":"1,320,975.00","total_whole":"1,320,975","shares_owned_after":90437.0,"shares_owned_after_display":"90,437","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-05-31","filed_date":"2011-06-01","scope":"insider"},{"id":9176861,"accession":"0001179110-11-009087","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001179110-11-009087","line_url":"/filing/0001179110-11-009087#line-4","is_derivative":false,"issuer_cik":"0001080014","issuer_name":"THERAVANCE INC","issuer_ticker":"THRX","issuer_name_source":null,"issuer_url":"/issuer/0001080014","owner_cik":"0001302445","owner_name":"Brinkley David L","owner_display_name":"Brinkley David L","owner_url":"/insider/0001302445","role":"Officer (Head of Business Dev)","role_mark":"O","role_mark_label":"Officer (Head of Business Dev)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Head of Business Dev.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":57812.0,"shares_display":"57,812","price_per_share":25.31,"price_display":"25.31","price_state":"stated","total_value":1463221.72,"total_display":"1,463,221.72","total_whole":"1,463,222","shares_owned_after":96496.0,"shares_owned_after_display":"96,496","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-05-27","filed_date":"2011-06-01","scope":"insider"},{"id":9077840,"accession":"0001179110-11-005180","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001179110-11-005180","line_url":"/filing/0001179110-11-005180#line-6","is_derivative":false,"issuer_cik":"0001080014","issuer_name":"THERAVANCE INC","issuer_ticker":"THRX","issuer_name_source":null,"issuer_url":"/issuer/0001080014","owner_cik":"0001302445","owner_name":"Brinkley David L","owner_display_name":"Brinkley David L","owner_url":"/insider/0001302445","role":"Officer (Head of Business Dev)","role_mark":"O","role_mark_label":"Officer (Head of Business Dev)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Head of Business Dev.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2100.0,"shares_display":"2,100","price_per_share":22.02,"price_display":"22.02","price_state":"stated","total_value":46242.0,"total_display":"46,242.00","total_whole":"46,242","shares_owned_after":98379.0,"shares_owned_after_display":"98,379","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-03-16","filed_date":"2011-03-17","scope":"insider"},{"id":9077838,"accession":"0001179110-11-005180","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001179110-11-005180","line_url":"/filing/0001179110-11-005180#line-4","is_derivative":false,"issuer_cik":"0001080014","issuer_name":"THERAVANCE INC","issuer_ticker":"THRX","issuer_name_source":null,"issuer_url":"/issuer/0001080014","owner_cik":"0001302445","owner_name":"Brinkley David L","owner_display_name":"Brinkley David L","owner_url":"/insider/0001302445","role":"Officer (Head of Business Dev)","role_mark":"O","role_mark_label":"Officer (Head of Business Dev)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Head of Business Dev.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":45492.0,"shares_display":"45,492","price_per_share":22.08,"price_display":"22.08","price_state":"stated","total_value":1004463.36,"total_display":"1,004,463.36","total_whole":"1,004,463","shares_owned_after":98379.0,"shares_owned_after_display":"98,379","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-03-15","filed_date":"2011-03-17","scope":"insider"},{"id":7684599,"accession":"0001179110-10-016948","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-10-016948","line_url":"/filing/0001179110-10-016948#line-2","is_derivative":false,"issuer_cik":"0001080014","issuer_name":"THERAVANCE INC","issuer_ticker":"THRX","issuer_name_source":null,"issuer_url":"/issuer/0001080014","owner_cik":"0001302445","owner_name":"Brinkley David L","owner_display_name":"Brinkley David L","owner_url":"/insider/0001302445","role":"Officer (Head of Business Dev)","role_mark":"O","role_mark_label":"Officer (Head of Business Dev)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Head of Business Dev.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":25.07,"price_display":"25.07","price_state":"stated","total_value":501400.0,"total_display":"501,400.00","total_whole":"501,400","shares_owned_after":38359.0,"shares_owned_after_display":"38,359","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-12-01","filed_date":"2010-12-03","scope":"insider"},{"id":7173403,"accession":"0001179110-10-013916","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-10-013916","line_url":"/filing/0001179110-10-013916#line-1","is_derivative":false,"issuer_cik":"0001080014","issuer_name":"THERAVANCE INC","issuer_ticker":"THRX","issuer_name_source":null,"issuer_url":"/issuer/0001080014","owner_cik":"0001302445","owner_name":"Brinkley David L","owner_display_name":"Brinkley David L","owner_url":"/insider/0001302445","role":"Officer (Head of Business Dev)","role_mark":"O","role_mark_label":"Officer (Head of Business Dev)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Head of Business Dev.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1980.0,"shares_display":"1,980","price_per_share":15.12,"price_display":"15.12","price_state":"stated","total_value":29937.6,"total_display":"29,937.60","total_whole":"29,938","shares_owned_after":32351.0,"shares_owned_after_display":"32,351","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-09-14","filed_date":"2010-09-16","scope":"insider"},{"id":7460454,"accession":"0001179110-10-010647","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001179110-10-010647","line_url":"/filing/0001179110-10-010647#line-4","is_derivative":false,"issuer_cik":"0001080014","issuer_name":"THERAVANCE INC","issuer_ticker":"THRX","issuer_name_source":null,"issuer_url":"/issuer/0001080014","owner_cik":"0001302445","owner_name":"Brinkley David L","owner_display_name":"Brinkley David L","owner_url":"/insider/0001302445","role":"Officer (Head of Business Dev)","role_mark":"O","role_mark_label":"Officer (Head of Business Dev)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Head of Business Dev.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":33516.0,"shares_display":"33,516","price_per_share":15.45,"price_display":"15.45","price_state":"stated","total_value":517822.2,"total_display":"517,822.20","total_whole":"517,822","shares_owned_after":35238.0,"shares_owned_after_display":"35,238","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-06-15","filed_date":"2010-06-16","scope":"insider"},{"id":7460449,"accession":"0001179110-10-010647","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-10-010647","line_url":"/filing/0001179110-10-010647#line-2","is_derivative":false,"issuer_cik":"0001080014","issuer_name":"THERAVANCE INC","issuer_ticker":"THRX","issuer_name_source":null,"issuer_url":"/issuer/0001080014","owner_cik":"0001302445","owner_name":"Brinkley David L","owner_display_name":"Brinkley David L","owner_url":"/insider/0001302445","role":"Officer (Head of Business Dev)","role_mark":"O","role_mark_label":"Officer (Head of Business Dev)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Head of Business Dev.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":33516.0,"shares_display":"33,516","price_per_share":15.65,"price_display":"15.65","price_state":"stated","total_value":524525.4,"total_display":"524,525.40","total_whole":"524,525","shares_owned_after":35238.0,"shares_owned_after_display":"35,238","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-06-14","filed_date":"2010-06-16","scope":"insider"},{"id":5612016,"accession":"0001179110-09-017238","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-09-017238","line_url":"/filing/0001179110-09-017238#line-1","is_derivative":false,"issuer_cik":"0001080014","issuer_name":"THERAVANCE INC","issuer_ticker":"THRX","issuer_name_source":null,"issuer_url":"/issuer/0001080014","owner_cik":"0001302445","owner_name":"Brinkley David L","owner_display_name":"Brinkley David L","owner_url":"/insider/0001302445","role":"Officer (Head of Business Dev)","role_mark":"O","role_mark_label":"Officer (Head of Business Dev)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Head of Business Dev.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1956.0,"shares_display":"1,956","price_per_share":13.01,"price_display":"13.01","price_state":"stated","total_value":25447.56,"total_display":"25,447.56","total_whole":"25,448","shares_owned_after":11547.0,"shares_owned_after_display":"11,547","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-12-16","filed_date":"2009-12-18","scope":"insider"},{"id":5831755,"accession":"0001179110-09-013313","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-09-013313","line_url":"/filing/0001179110-09-013313#line-2","is_derivative":false,"issuer_cik":"0001080014","issuer_name":"THERAVANCE INC","issuer_ticker":"THRX","issuer_name_source":null,"issuer_url":"/issuer/0001080014","owner_cik":"0001302445","owner_name":"Brinkley David L","owner_display_name":"Brinkley David L","owner_url":"/insider/0001302445","role":"Officer (Head of Business Dev)","role_mark":"O","role_mark_label":"Officer (Head of Business Dev)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Head of Business Dev.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9000.0,"shares_display":"9,000","price_per_share":17.8564,"price_display":"17.86","price_state":"stated","total_value":160707.6,"total_display":"160,707.60","total_whole":"160,708","shares_owned_after":14207.0,"shares_owned_after_display":"14,207","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-09-15","filed_date":"2009-09-16","scope":"insider"},{"id":7880667,"accession":"0001179110-07-023532","txn_seq":15,"anchor":"line-15","filing_url":"/filing/0001179110-07-023532","line_url":"/filing/0001179110-07-023532","is_derivative":false,"issuer_cik":"0001080014","issuer_name":"THERAVANCE INC","issuer_ticker":"THRX","issuer_name_source":null,"issuer_url":"/issuer/0001080014","owner_cik":"0001302445","owner_name":"Brinkley David L","owner_display_name":"Brinkley David L","owner_url":"/insider/0001302445","role":"Officer (Sr. VP Commercial Development)","role_mark":"O","role_mark_label":"Officer (Sr. VP Commercial Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP Commercial Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4439.0,"shares_display":"4,439","price_per_share":22.591538634827664,"price_display":"22.59","price_state":"stated","total_value":100283.84,"total_display":"100,283.84","total_whole":"100,284","shares_owned_after":19536.0,"shares_owned_after_display":"19,536","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-12-14","filed_date":"2007-12-14","scope":"insider","n_lines":15},{"id":7026898,"accession":"0001179110-07-018375","txn_seq":21,"anchor":"line-21","filing_url":"/filing/0001179110-07-018375","line_url":"/filing/0001179110-07-018375#line-21","is_derivative":false,"issuer_cik":"0001080014","issuer_name":"THERAVANCE INC","issuer_ticker":"THRX","issuer_name_source":null,"issuer_url":"/issuer/0001080014","owner_cik":"0001302445","owner_name":"Brinkley David L","owner_display_name":"Brinkley David L","owner_url":"/insider/0001302445","role":"Officer (Sr. VP Commercial Development)","role_mark":"O","role_mark_label":"Officer (Sr. VP Commercial Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP Commercial Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":500.0,"shares_display":"500","price_per_share":27.79,"price_display":"27.79","price_state":"stated","total_value":13895.0,"total_display":"13,895.00","total_whole":"13,895","shares_owned_after":23436.0,"shares_owned_after_display":"23,436","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-09-14","filed_date":"2007-09-14","scope":"insider"},{"id":7026896,"accession":"0001179110-07-018375","txn_seq":20,"anchor":"line-20","filing_url":"/filing/0001179110-07-018375","line_url":"/filing/0001179110-07-018375#line-20","is_derivative":false,"issuer_cik":"0001080014","issuer_name":"THERAVANCE INC","issuer_ticker":"THRX","issuer_name_source":null,"issuer_url":"/issuer/0001080014","owner_cik":"0001302445","owner_name":"Brinkley David L","owner_display_name":"Brinkley David L","owner_url":"/insider/0001302445","role":"Officer (Sr. VP Commercial Development)","role_mark":"O","role_mark_label":"Officer (Sr. VP Commercial Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP Commercial Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":401.0,"shares_display":"401","price_per_share":27.64,"price_display":"27.64","price_state":"stated","total_value":11083.64,"total_display":"11,083.64","total_whole":"11,084","shares_owned_after":25636.0,"shares_owned_after_display":"25,636","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-09-14","filed_date":"2007-09-14","scope":"insider"},{"id":7026895,"accession":"0001179110-07-018375","txn_seq":19,"anchor":"line-19","filing_url":"/filing/0001179110-07-018375","line_url":"/filing/0001179110-07-018375#line-19","is_derivative":false,"issuer_cik":"0001080014","issuer_name":"THERAVANCE INC","issuer_ticker":"THRX","issuer_name_source":null,"issuer_url":"/issuer/0001080014","owner_cik":"0001302445","owner_name":"Brinkley David L","owner_display_name":"Brinkley David L","owner_url":"/insider/0001302445","role":"Officer (Sr. VP Commercial Development)","role_mark":"O","role_mark_label":"Officer (Sr. VP Commercial Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP Commercial Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":300.0,"shares_display":"300","price_per_share":27.73,"price_display":"27.73","price_state":"stated","total_value":8319.0,"total_display":"8,319.00","total_whole":"8,319","shares_owned_after":24136.0,"shares_owned_after_display":"24,136","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-09-14","filed_date":"2007-09-14","scope":"insider"},{"id":7026893,"accession":"0001179110-07-018375","txn_seq":18,"anchor":"line-18","filing_url":"/filing/0001179110-07-018375","line_url":"/filing/0001179110-07-018375#line-18","is_derivative":false,"issuer_cik":"0001080014","issuer_name":"THERAVANCE INC","issuer_ticker":"THRX","issuer_name_source":null,"issuer_url":"/issuer/0001080014","owner_cik":"0001302445","owner_name":"Brinkley David L","owner_display_name":"Brinkley David L","owner_url":"/insider/0001302445","role":"Officer (Sr. VP Commercial Development)","role_mark":"O","role_mark_label":"Officer (Sr. VP Commercial Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP Commercial Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":300.0,"shares_display":"300","price_per_share":27.67,"price_display":"27.67","price_state":"stated","total_value":8301.0,"total_display":"8,301.00","total_whole":"8,301","shares_owned_after":25136.0,"shares_owned_after_display":"25,136","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-09-14","filed_date":"2007-09-14","scope":"insider"},{"id":7026891,"accession":"0001179110-07-018375","txn_seq":17,"anchor":"line-17","filing_url":"/filing/0001179110-07-018375","line_url":"/filing/0001179110-07-018375#line-17","is_derivative":false,"issuer_cik":"0001080014","issuer_name":"THERAVANCE INC","issuer_ticker":"THRX","issuer_name_source":null,"issuer_url":"/issuer/0001080014","owner_cik":"0001302445","owner_name":"Brinkley David L","owner_display_name":"Brinkley David L","owner_url":"/insider/0001302445","role":"Officer (Sr. VP Commercial Development)","role_mark":"O","role_mark_label":"Officer (Sr. VP Commercial Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP Commercial Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":299.0,"shares_display":"299","price_per_share":27.68,"price_display":"27.68","price_state":"stated","total_value":8276.32,"total_display":"8,276.32","total_whole":"8,276","shares_owned_after":24837.0,"shares_owned_after_display":"24,837","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-09-14","filed_date":"2007-09-14","scope":"insider"},{"id":7026888,"accession":"0001179110-07-018375","txn_seq":16,"anchor":"line-16","filing_url":"/filing/0001179110-07-018375","line_url":"/filing/0001179110-07-018375#line-16","is_derivative":false,"issuer_cik":"0001080014","issuer_name":"THERAVANCE INC","issuer_ticker":"THRX","issuer_name_source":null,"issuer_url":"/issuer/0001080014","owner_cik":"0001302445","owner_name":"Brinkley David L","owner_display_name":"Brinkley David L","owner_url":"/insider/0001302445","role":"Officer (Sr. VP Commercial Development)","role_mark":"O","role_mark_label":"Officer (Sr. VP Commercial Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP Commercial Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200.0,"shares_display":"200","price_per_share":27.72,"price_display":"27.72","price_state":"stated","total_value":5544.0,"total_display":"5,544.00","total_whole":"5,544","shares_owned_after":24436.0,"shares_owned_after_display":"24,436","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-09-14","filed_date":"2007-09-14","scope":"insider"},{"id":7026885,"accession":"0001179110-07-018375","txn_seq":15,"anchor":"line-15","filing_url":"/filing/0001179110-07-018375","line_url":"/filing/0001179110-07-018375#line-15","is_derivative":false,"issuer_cik":"0001080014","issuer_name":"THERAVANCE INC","issuer_ticker":"THRX","issuer_name_source":null,"issuer_url":"/issuer/0001080014","owner_cik":"0001302445","owner_name":"Brinkley David L","owner_display_name":"Brinkley David L","owner_url":"/insider/0001302445","role":"Officer (Sr. VP Commercial Development)","role_mark":"O","role_mark_label":"Officer (Sr. VP Commercial Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP Commercial Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200.0,"shares_display":"200","price_per_share":27.56,"price_display":"27.56","price_state":"stated","total_value":5512.0,"total_display":"5,512.00","total_whole":"5,512","shares_owned_after":26459.0,"shares_owned_after_display":"26,459","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-09-14","filed_date":"2007-09-14","scope":"insider"},{"id":7026882,"accession":"0001179110-07-018375","txn_seq":14,"anchor":"line-14","filing_url":"/filing/0001179110-07-018375","line_url":"/filing/0001179110-07-018375#line-14","is_derivative":false,"issuer_cik":"0001080014","issuer_name":"THERAVANCE INC","issuer_ticker":"THRX","issuer_name_source":null,"issuer_url":"/issuer/0001080014","owner_cik":"0001302445","owner_name":"Brinkley David L","owner_display_name":"Brinkley David L","owner_url":"/insider/0001302445","role":"Officer (Sr. VP Commercial Development)","role_mark":"O","role_mark_label":"Officer (Sr. VP Commercial Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP Commercial Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":122.0,"shares_display":"122","price_per_share":27.61,"price_display":"27.61","price_state":"stated","total_value":3368.42,"total_display":"3,368.42","total_whole":"3,368","shares_owned_after":26137.0,"shares_owned_after_display":"26,137","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-09-14","filed_date":"2007-09-14","scope":"insider"},{"id":7026880,"accession":"0001179110-07-018375","txn_seq":13,"anchor":"line-13","filing_url":"/filing/0001179110-07-018375","line_url":"/filing/0001179110-07-018375#line-13","is_derivative":false,"issuer_cik":"0001080014","issuer_name":"THERAVANCE INC","issuer_ticker":"THRX","issuer_name_source":null,"issuer_url":"/issuer/0001080014","owner_cik":"0001302445","owner_name":"Brinkley David L","owner_display_name":"Brinkley David L","owner_url":"/insider/0001302445","role":"Officer (Sr. VP Commercial Development)","role_mark":"O","role_mark_label":"Officer (Sr. VP Commercial Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP Commercial Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":101.0,"shares_display":"101","price_per_share":27.69,"price_display":"27.69","price_state":"stated","total_value":2796.69,"total_display":"2,796.69","total_whole":"2,797","shares_owned_after":24736.0,"shares_owned_after_display":"24,736","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-09-14","filed_date":"2007-09-14","scope":"insider"},{"id":7026877,"accession":"0001179110-07-018375","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0001179110-07-018375","line_url":"/filing/0001179110-07-018375#line-12","is_derivative":false,"issuer_cik":"0001080014","issuer_name":"THERAVANCE INC","issuer_ticker":"THRX","issuer_name_source":null,"issuer_url":"/issuer/0001080014","owner_cik":"0001302445","owner_name":"Brinkley David L","owner_display_name":"Brinkley David L","owner_url":"/insider/0001302445","role":"Officer (Sr. VP Commercial Development)","role_mark":"O","role_mark_label":"Officer (Sr. VP Commercial Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP Commercial Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":27.78,"price_display":"27.78","price_state":"stated","total_value":2778.0,"total_display":"2,778.00","total_whole":"2,778","shares_owned_after":23936.0,"shares_owned_after_display":"23,936","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-09-14","filed_date":"2007-09-14","scope":"insider"},{"id":7026874,"accession":"0001179110-07-018375","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0001179110-07-018375","line_url":"/filing/0001179110-07-018375#line-11","is_derivative":false,"issuer_cik":"0001080014","issuer_name":"THERAVANCE INC","issuer_ticker":"THRX","issuer_name_source":null,"issuer_url":"/issuer/0001080014","owner_cik":"0001302445","owner_name":"Brinkley David L","owner_display_name":"Brinkley David L","owner_url":"/insider/0001302445","role":"Officer (Sr. VP Commercial Development)","role_mark":"O","role_mark_label":"Officer (Sr. VP Commercial Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP Commercial Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":27.75,"price_display":"27.75","price_state":"stated","total_value":2775.0,"total_display":"2,775.00","total_whole":"2,775","shares_owned_after":24036.0,"shares_owned_after_display":"24,036","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-09-14","filed_date":"2007-09-14","scope":"insider"},{"id":7026871,"accession":"0001179110-07-018375","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001179110-07-018375","line_url":"/filing/0001179110-07-018375#line-10","is_derivative":false,"issuer_cik":"0001080014","issuer_name":"THERAVANCE INC","issuer_ticker":"THRX","issuer_name_source":null,"issuer_url":"/issuer/0001080014","owner_cik":"0001302445","owner_name":"Brinkley David L","owner_display_name":"Brinkley David L","owner_url":"/insider/0001302445","role":"Officer (Sr. VP Commercial Development)","role_mark":"O","role_mark_label":"Officer (Sr. VP Commercial Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP Commercial Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":27.7,"price_display":"27.70","price_state":"stated","total_value":2770.0,"total_display":"2,770.00","total_whole":"2,770","shares_owned_after":24636.0,"shares_owned_after_display":"24,636","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-09-14","filed_date":"2007-09-14","scope":"insider"},{"id":7026868,"accession":"0001179110-07-018375","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001179110-07-018375","line_url":"/filing/0001179110-07-018375#line-9","is_derivative":false,"issuer_cik":"0001080014","issuer_name":"THERAVANCE INC","issuer_ticker":"THRX","issuer_name_source":null,"issuer_url":"/issuer/0001080014","owner_cik":"0001302445","owner_name":"Brinkley David L","owner_display_name":"Brinkley David L","owner_url":"/insider/0001302445","role":"Officer (Sr. VP Commercial Development)","role_mark":"O","role_mark_label":"Officer (Sr. VP Commercial Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP Commercial Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":27.66,"price_display":"27.66","price_state":"stated","total_value":2766.0,"total_display":"2,766.00","total_whole":"2,766","shares_owned_after":25436.0,"shares_owned_after_display":"25,436","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-09-14","filed_date":"2007-09-14","scope":"insider"},{"id":7026866,"accession":"0001179110-07-018375","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001179110-07-018375","line_url":"/filing/0001179110-07-018375#line-8","is_derivative":false,"issuer_cik":"0001080014","issuer_name":"THERAVANCE INC","issuer_ticker":"THRX","issuer_name_source":null,"issuer_url":"/issuer/0001080014","owner_cik":"0001302445","owner_name":"Brinkley David L","owner_display_name":"Brinkley David L","owner_url":"/insider/0001302445","role":"Officer (Sr. VP Commercial Development)","role_mark":"O","role_mark_label":"Officer (Sr. VP Commercial Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP Commercial Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":27.65,"price_display":"27.65","price_state":"stated","total_value":2765.0,"total_display":"2,765.00","total_whole":"2,765","shares_owned_after":25536.0,"shares_owned_after_display":"25,536","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-09-14","filed_date":"2007-09-14","scope":"insider"},{"id":7026863,"accession":"0001179110-07-018375","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001179110-07-018375","line_url":"/filing/0001179110-07-018375#line-7","is_derivative":false,"issuer_cik":"0001080014","issuer_name":"THERAVANCE INC","issuer_ticker":"THRX","issuer_name_source":null,"issuer_url":"/issuer/0001080014","owner_cik":"0001302445","owner_name":"Brinkley David L","owner_display_name":"Brinkley David L","owner_url":"/insider/0001302445","role":"Officer (Sr. VP Commercial Development)","role_mark":"O","role_mark_label":"Officer (Sr. VP Commercial Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP Commercial Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":27.63,"price_display":"27.63","price_state":"stated","total_value":2763.0,"total_display":"2,763.00","total_whole":"2,763","shares_owned_after":26037.0,"shares_owned_after_display":"26,037","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-09-14","filed_date":"2007-09-14","scope":"insider"},{"id":7026860,"accession":"0001179110-07-018375","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001179110-07-018375","line_url":"/filing/0001179110-07-018375#line-6","is_derivative":false,"issuer_cik":"0001080014","issuer_name":"THERAVANCE INC","issuer_ticker":"THRX","issuer_name_source":null,"issuer_url":"/issuer/0001080014","owner_cik":"0001302445","owner_name":"Brinkley David L","owner_display_name":"Brinkley David L","owner_url":"/insider/0001302445","role":"Officer (Sr. VP Commercial Development)","role_mark":"O","role_mark_label":"Officer (Sr. VP Commercial Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP Commercial Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":27.58,"price_display":"27.58","price_state":"stated","total_value":2758.0,"total_display":"2,758.00","total_whole":"2,758","shares_owned_after":26259.0,"shares_owned_after_display":"26,259","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-09-14","filed_date":"2007-09-14","scope":"insider"},{"id":7026857,"accession":"0001179110-07-018375","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001179110-07-018375","line_url":"/filing/0001179110-07-018375#line-5","is_derivative":false,"issuer_cik":"0001080014","issuer_name":"THERAVANCE INC","issuer_ticker":"THRX","issuer_name_source":null,"issuer_url":"/issuer/0001080014","owner_cik":"0001302445","owner_name":"Brinkley David L","owner_display_name":"Brinkley David L","owner_url":"/insider/0001302445","role":"Officer (Sr. VP Commercial Development)","role_mark":"O","role_mark_label":"Officer (Sr. VP Commercial Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP Commercial Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":27.57,"price_display":"27.57","price_state":"stated","total_value":2757.0,"total_display":"2,757.00","total_whole":"2,757","shares_owned_after":26359.0,"shares_owned_after_display":"26,359","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-09-14","filed_date":"2007-09-14","scope":"insider"},{"id":7026855,"accession":"0001179110-07-018375","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001179110-07-018375","line_url":"/filing/0001179110-07-018375#line-4","is_derivative":false,"issuer_cik":"0001080014","issuer_name":"THERAVANCE INC","issuer_ticker":"THRX","issuer_name_source":null,"issuer_url":"/issuer/0001080014","owner_cik":"0001302445","owner_name":"Brinkley David L","owner_display_name":"Brinkley David L","owner_url":"/insider/0001302445","role":"Officer (Sr. VP Commercial Development)","role_mark":"O","role_mark_label":"Officer (Sr. VP Commercial Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP Commercial Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":27.55,"price_display":"27.55","price_state":"stated","total_value":2755.0,"total_display":"2,755.00","total_whole":"2,755","shares_owned_after":26659.0,"shares_owned_after_display":"26,659","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-09-14","filed_date":"2007-09-14","scope":"insider"}],"collapsed":true,"next_cursor":"2007-09-14|7026855","ledger_fault":false,"count":{"value":65,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":65,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":65},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001080014","name":"THERAVANCE INC","url":"/issuer/0001080014","role":"Officer (Head of Business Dev)","n_filings":17,"first_seen":"2007-03-02","last_seen":"2013-05-31"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001302445","retrieved_at":"2026-08-24T04:56:12+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}